Login / Signup

Safety and Efficacy of VIT against Wasp Venom in Ultra-Rush Protocols in Patients Older Than 60 Years.

Andrzej BozekJanne WintersteinRobert PawłowiczIan PoiansDominika SadowskaMartyna MiodonskaMarita Nittner-Marszalska
Published in: Vaccines (2024)
VIT against wasp venom is safe and effective in short-term observation, and is comparable to that used for young patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • prognostic factors
  • physical activity
  • patient reported outcomes